Close

Refine your search

Specimen under microscope.

SYLI – Living Biobank – Cancer Laboratory Project Kick-off

The project´s aim is to create a new research, development and innovation infrastructure and service model in Kuopio
  • Publication event
  • Research
  • University-business cooperation
  • Technology and innovations
Event date:
Time:
12:00–15:30
Event location:
Kuopio campus, Snellmania building, room SN205, and online
Additional information:
Yliopistonranta 8
Add to calendar:
Google Outlook iCal

We warmly welcome academic and industry stakeholders to the launch of SYLI – Living Biobank – Cancer Laboratory on 9 December 2025. The event will be held as a hybrid event, in collaboration with the projects UEF clinical RDI-ecosystem (UEF-TKI) and Clinical RDI-ecosystem of North Savo wellbeing services county (PSHVA-TKI, in Finnish). Registration is required. Please register to the event through this link by 5 December. The Workshop can also be attended either virtually or on-site. Instructions how to come to the Cell and Tissue Imaging Unit will be sent to registered.

SYLI project is creating a new RDI infrastructure and service model in Kuopio to accelerate translational cancer research and support industry-driven innovation.

The project brings together biobank samples, high-content imaging, single-cell technologies, and bioinformatics under one integrated service concept.

Program

12:00–13:00   Open House at the Cell and Tissue Imaging Unit: visit the state-of- the-art imaging lab and learn how it supports translational cancer research.

13:00–14:10   Webinar (in Finnish) by the UEF/PSHVA Clinical RDI-Ecosystem Project. The webinar will present regional research and innovation collaboration, and key clinical RDI environments that support both research and industry needs. Room SN205 and on-line.

14:10–14:30   Break, Coffee, Networking

14:30–15:25   Workshop for Companies and Collaborators: Introduction to SYLI – Living Biobank – Cancer laboratory project. Discuss on future service concepts and partnership opportunities within the SYLI framework. 
Project Manager Mikko Karjalainen and Research Director Kirsi Ketola, University of Eastern Finland. Room SN205 and on-line.

15:25–15:30   Wrap-up

For more information, please contact:
Project Manager Mikko Karjalainen, [email protected] or 
Research Director Kirsi Ketola, [email protected].  
 

Co-funded by the European Union
Regional Council of Pohjois-Savo, logo

Arrival instructions and parking on campus

Related content

Blue circle.

Living biobank - Cancer Laboratory SYLI (Investment)

Ongoing

Living Biobank – The Cancer Laboratory is both a development and investment project .The University of Eastern Finland has significantly invested in developing methods for analyzing patient-derived samples, such as cancer patient samples, and enhancing RDI infrastructures, including microscopic high-throughput screening, sequencing, computational capacity, and the latest AI methods, particularly machine learning. This development has been carried out in close collaboration with the Biobank of Eastern Finland. These advancements now open up new opportunities for other organizations and companies that utilize biological samples but previously had not recognized the potential of these methods or had not had access to them for RDI activities or business operations. The goal of the project is to integrate the existing infrastructure and related specialized expertise, and establish a new RDI infrastructure, the Cancer Laboratory, at the University of Eastern Finland through key instrument acquisition (investment project), and to create an operational concept and comprehensive service model in close cooperation with the regional business community. The long-term objective of this development and investment project is to establish service portfolio in North Savo, where through biobank cooperation, patients and citizens can be more actively involved in RDI activities. The introduction of new high technologies and the development of new RDI services within the project will create opportunities for new business-driven innovations and provide significant health benefits to healthcare. The Living Biobank – Cancer Laboratory will acquire (investment project) a cell diagnostic device for isolating cancer cells from the bloodstream, a plate pipetting robot for more efficient automation of sample processing, and tissue sample processing equipment for the processing of histological cancer patient samples. These equipment purchases are centrally involved in the service concept of the development project, which is implemented in close cooperation with the business community (WP1, TP2). The concept will be tested in two pilots (TP3). A new operational model and service will be created around the sample workflow, where a requested sample from the Biobank of Eastern Finland will be processed (e.g., with a pharmaceutical agent) and then analyzed microscopically and bioinformatically. This type of service concept is unique. The service concept and the progress of the project will be effectively communicated for the local healthcare ecosystem members and for the potential concept users locally, nationally and internationally (TP4). The project promotes the utilization of new technologies and infrastructure at the University of Eastern Finland, increases cooperation between the university and the business community, and simultaneously creates growth and jobs in the region. The project consists of development and investment initiatives. In the Cancer Laboratory investment project, existing key equipment will be supplemented, enabling the development of a new service concept in the Living biobank – Cancer Laboratory development project.

Read more

Blue circle.

Living biobank - Cancer Laboratory SYLI (Development)

Ongoing

The University of Eastern Finland has significantly invested in developing methods for analyzing patient-derived samples, such as cancer patient samples, and enhancing RDI infrastructures, including microscopic high-throughput screening, sequencing, computational capacity, and the latest AI methods, particularly machine learning. This development has been carried out in close collaboration with the Biobank of Eastern Finland. These advancements now open up new opportunities for other organizations and companies that utilize biological samples but previously had not recognized the potential of these methods or had not had access to them for RDI activities or business operations. The goal of the project is to integrate the existing infrastructure and related specialized expertise, and establish a new RDI infrastructure, the Cancer Laboratory, at the University of Eastern Finland through key instrument acquisition (investment project), and to create an operational concept and comprehensive service model in close cooperation with the regional business community. The long-term objective of this development and investment project is to establish service portfolio in North Savo, where through biobank cooperation, patients and citizens can be more actively involved in RDI activities. The introduction of new high technologies and the development of new RDI services within the project will create opportunities for new business-driven innovations and provide significant health benefits to healthcare. In the project, a service concept for the Cancer Laboratory will be created in close collaboration with the business community (TP1 and TP2) and tested in two pilots (TP3). A new operational model and service will be created around the sample workflow, where a requested sample from the Biobank of Eastern Finland will be processed (e.g., with a pharmaceutical agent) and then analyzed microscopically and bioinformatically. This type of service concept is unique. The service concept and the progress of the project will be effectively communicated for the local healthcare ecosystem members and for the potential concept users locally, nationally and internationally (TP4). The project promotes the utilization of new technologies and infrastructure at the University of Eastern Finland, increases cooperation between the university and the business community, and simultaneously creates growth and jobs in the region. The project consists of development and investment initiatives. In the Cancer Laboratory investment project, existing key equipment will be supplemented, enabling the development of a new service concept in the Cancer Laboratory development project.

Read more